These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22918160)

  • 1. Standardized care management ensures similar survival rates in HIV-positive and HIV-negative patients with hepatocellular carcinoma.
    Lim C; Goutte N; Gervais A; Vullierme MP; Valla DC; Degos F; Farges O
    J Acquir Immune Defic Syndr; 2012 Dec; 61(5):581-7. PubMed ID: 22918160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary Management of Hepatocellular Carcinoma Improves Access to Therapy and Patient Survival.
    Agarwal PD; Phillips P; Hillman L; Lucey MR; Lee F; Mezrich JD; Said A
    J Clin Gastroenterol; 2017 Oct; 51(9):845-849. PubMed ID: 28877082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
    Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
    Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Presentation and Outcome After Liver Resection of Patients With Hepatocellular Carcinoma With and Without HIV.
    Zhao H; Li J; Li S; Wang Y; Zhou J; Liu L; Wang C
    J Acquir Immune Defic Syndr; 2021 Mar; 86(3):361-368. PubMed ID: 33165126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort.
    Gelu-Simeon M; Lewin M; Ostos M; Bayan T; Beso Delgado M; Teicher E; Layese R; Roudot-Thoraval F; Fontaine H; Sobesky R; Salmon-Céron D; Samuel D; Seror O; Nahon P; Meyer L; Duclos-Vallée JC;
    Liver Int; 2019 Jan; 39(1):136-146. PubMed ID: 29947467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome.
    Puoti M; Bruno R; Soriano V; Donato F; Gaeta GB; Quinzan GP; Precone D; Gelatti U; Asensi V; Vaccher E;
    AIDS; 2004 Nov; 18(17):2285-93. PubMed ID: 15577541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.
    Goutté N; Sogni P; Bendersky N; Barbare JC; Falissard B; Farges O
    J Hepatol; 2017 Mar; 66(3):537-544. PubMed ID: 27773614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular Carcinoma in a Tertiary Referral Hospital in Indonesia: Lack of Improvement of One-Year Survival Rates between 1998-1999 and 2013-2014.
    Loho IM; Hasan I; Lesmana CR; Dewiasty E; Gani RA
    Asian Pac J Cancer Prev; 2016; 17(4):2165-70. PubMed ID: 27221913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
    Bräu N; Fox RK; Xiao P; Marks K; Naqvi Z; Taylor LE; Trikha A; Sherman M; Sulkowski MS; Dieterich DT; Rigsby MO; Wright TL; Hernandez MD; Jain MK; Khatri GK; Sterling RK; Bonacini M; Martyn CA; Aytaman A; Llovet JM; Brown ST; Bini EJ;
    J Hepatol; 2007 Oct; 47(4):527-37. PubMed ID: 17692986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, treatment, and clinical outcomes of patients with hepatocellular carcinoma, with and without human immunodeficiency virus infection.
    Yopp AC; Subramanian M; Jain MK; Mansour JC; Schwarz RE; Balch GC; Singal AG
    Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1284-90. PubMed ID: 22902759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma.
    Agüero F; Forner A; Manzardo C; Valdivieso A; Blanes M; Barcena R; Rafecas A; Castells L; Abradelo M; Torre-Cisneros J; Gonzalez-Dieguez L; Salcedo M; Serrano T; Jimenez-Perez M; Herrero JI; Gastaca M; Aguilera V; Fabregat J; Del Campo S; Bilbao I; Romero CJ; Moreno A; Rimola A; Miro JM;
    Hepatology; 2016 Feb; 63(2):488-98. PubMed ID: 26516761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients.
    Sinn DH; Choi GS; Park HC; Kim JM; Kim H; Song KD; Kang TW; Lee MW; Rhim H; Hyun D; Cho SK; Shin SW; Jeong WK; Kim SH; Yu JI; Ha SY; Lee SJ; Lim HY; Kim K; Ahn JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Joh JW; Lim HK; Paik SW
    PLoS One; 2019; 14(1):e0210730. PubMed ID: 30640924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.
    Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcatheter arterial chemoembolisation for hepatocellular carcinoma in cirrhosis: survival rate and prognostic factors.
    Olivo M; Valenza F; Buccellato A; Scala L; Virdone R; Sciarrino E; Di Piazza S; Marrone C; Orlando A; Fusco G; Madonia S; Cottone M
    Dig Liver Dis; 2010 Jul; 42(7):515-9. PubMed ID: 19914153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective evaluation of the management of hepatocellular carcinoma in the elderly.
    Ozenne V; Bouattour M; Goutté N; Vullierme MP; Ripault MP; Castelnau C; Valla DC; Degos F; Farges O
    Dig Liver Dis; 2011 Dec; 43(12):1001-5. PubMed ID: 21798829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of HIV on hepatocellular cancer survival in Nigeria.
    Okeke E; Mark Davwar P; Mullen B; Duguru M; Agbaji O; Sagay A; Murphy R; Hawkins C
    Trop Med Int Health; 2021 Mar; 26(3):335-342. PubMed ID: 33244817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
    Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
    J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
    Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
    Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.